Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.19 USD | +0.98% | +3.01% | -35.92% |
05-15 | HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating | MT |
05-14 | Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.92% | 196M | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-1.02% | 21.97B | |
-4.83% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- FENC Stock
- News Fennec Pharmaceuticals Inc.
- Fennec Pharmaceuticals : Earnings Flash (FRX.TO) FENNEC PHARMACEUTICALS Posts Net loss for Q2 was US$4.0 million ($0.15 per share), compared to $4.8 million ($0.21 per share) for the same period in 202